.FDA denies psychedelic MDMA-assisted treatment for post-traumatic stress disorder NBC NewsF.D.A. Declines to Accept MDMA Treatment, Looking For More Study The New York City TimesFDA Denies Ecstasy-Based Drug The Commercial JournalFDA declines to accept unfamiliar MDMA treatment to alleviate PTSD, along with ask for additional hearing data CNNFDA turns down to begin with psychedelic to treat post-traumatic stress disorder, requiring additional research study The Washington Post.